BIO – bio-rad laboratories, inc. class a (US:NASDAQ)
Stock Stats
News
Bio-Rad Laboratories (NYSE:BIO) was downgraded by analysts at Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
Bio-Rad Laboratories (NYSE:BIO) was upgraded by analysts at Wall Street Z
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Bio-Rad Laboratories (NYSE:BIO) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Wells Fargo & Company from $265.00 to $340.00. They now have an "equal weight" rating on the stock.
Form 144 BIO-RAD LABORATORIES, Filed by: Crowley Michael
Form 144 BIO-RAD LABORATORIES, Filed by: Alles Institute for Medical Research Corp
Form 4 BIO-RAD LABORATORIES, For: Nov 06 Filed by: BARRY JAMES
Form 144 BIO-RAD LABORATORIES, Filed by: BARRY JAMES
Form SCHEDULE 13D/A BIO-RAD LABORATORIES, Filed by: SCHWARTZ NORMAN D
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.